Share on Pinterest LeoPatrizi/Getty Images Semaglutide is the active ingredient in Wegovy, Ozempic, and Rybelsus. Currently, only Wegovy is approved for weight loss in the United States.

Image Credit: Caroline Ruda/Shutterstock.com In comparison to insulin treatment, semaglutide was found to significantly reduce the risk of first-time Alzheimer's disease (AD) diagnosis.

placebo. Adults with obesity lost about 21% of their body weight at 72 weeks with semaglutide 7.2 mg. Image: Adobe Stock In the trial product estimand, adults receiving semaglutide 7.2 mg had a ...

Semaglutide is a GLP-1 receptor agonist that selectively binds to and activates the GLP-1 receptor mimicking its activity. GLP-1 is an incretin hormone and enterogastrone that stimulates insulin ...